Transgene Biotek Ltd
₹3.08
+0.01
(+0.33%)
as on
Transgene Biotek Stock Performance
as on July 17, 2026 at 9:31 pm IST
Day's Low
Day's High
₹3.02₹3.14
1.95%
Downside
1.95%
Upside
52 Week's Low
52 Week's High
₹1.83₹5.2640.58%
Downside
70.78%
Upside
Transgene Biotek share price movements today
- Previous Close
- ₹3.07
- Open
- ₹3.03
- Volume
- 3,219.00
- Upper Circuit
- ₹3.68
- Lower Circuit
- ₹2.46
- Day's Low - High
- ₹3.02 - ₹3.14
- 52 Week Low - High
- ₹1.83 - ₹5.26
Transgene Biotek Historical Returns
- 1 Month Return
- + 1.99 %
- 3 Month Return
- -0.65 %
- 1 Year Return
- -37.09 %
- 3 Year Return
- -21.28 %
- 5 Year Return
- -28.6 %
Transgene Biotek Fundamentals
as on July 17, 2026 at 4:01 pm IST
Market Cap
₹23.26 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-13.95
Return on capital employed (ROCE)
0Industry PE ratio
58.26
Beta (LTM)
1.19
P/B Ratio
-3.35
Dividend Yield
0PEG Ratio
99.68
Quarterly Earnings Growth YOY
-35.21
EPS (TTM)
-0.09
Book Value
1.32
Transgene Biotek Stock Valuation
as on July 17, 2026 at 4:01 pm IST
Transgene Biotek in the last 5 years
Lowest (-227.67x)
December 31, 2024
Today (-13.95x)
July 16, 2026
Industry (58.26x)
July 16, 2026
Highest (13.23x)
October 8, 2018
Today’s Price to Earnings Ratio: -13.95x
Transgene Biotek Technical Analysis
Track how Transgene Biotek technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 0.01 | |
CCI (20) | 1.33 | Neutral |
RSI (14) | 51.25 | Neutral |
Momentum (10) | 0.01 | |
ADI (14) | 26.67 | Bullish |
Ultimate Oscillator (7,14,28) | 40.95 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 3.06 | Bullish |
EMA (20) | 3.06 | Bullish |
VWMA (20) | 3.07 | Bullish |
SMA (50) | 3.08 | Bullish |
EMA (50) | 3.02 | Bullish |
SMA (200) | 3.04 | Bullish |
EMA (200) | 3.2 | |
KAMA (200) | 2.87 | Bullish |
DEMA (200) | 2.55 | Bullish |
Transgene Biotek Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Transgene Biotek with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 23.26 | -5.72% | 0.96 | -1 | NA | |
| NA | 1,226.23 | 630.54% | 0.00 | 18 | 147 | |
| NA | 214.32 | 18.68% | 0.53 | 7 | 89 | |
| NA | 107.08 | -12.77% | 0.00 | 3 | 46 | |
| NA | 64.87 | -1.42% | 0.00 | 4 | 47 |
Transgene Biotek Stock’s Investor Sentiment and Interest
Search interest for Transgene Biotek Ltd Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:22% versus previous 30 day period
Transgene Biotek Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Transgene Biotek Ltd Annual Profit & Loss
Figures in Rupees Crores
Transgene Biotek Ltd Cash Flow
Figures in Rupees Crores
Transgene Biotek Corporate Actions
View detailed summary of the earnings and dividend history of Transgene Biotek.
Transgene Biotek Ltd Earnings Results
Transgene Biotek Ltd’s net profit jumped 35.21% since last year same period to ₹0.46Cr in the Q4 2025-2026. On a quarterly growth basis, Transgene Biotek Ltd has generated -24.32% fall in its net profits since last 3-months.
Read More about Earnings Results
Insights on Transgene Biotek Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 0.05 Cr → 0.2 Cr (in ₹), with an average increase of 75.0% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Vimta Labs Ltd has given 144.7% return, outperforming this stock by 166.0%
- NO EFFECT
Against Peers
In the last 1 year, Biocon Ltd has given 10.5% return, outperforming this stock by 47.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 21.68% of holdings in Mar 2026 quarter
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 70.04% of holdings in Mar 2026 quarter
NEGATIVE IMPACTPrice Dip
In the last 1 year, Transgene Biotek stock has moved down by -37.1%
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -0.37 Cr → -0.46 Cr (in ₹), with an average decrease of 24.3% per quarter
About Transgene Biotek Ltd
Revenue: ₹0.05Cr as on March 2026 (Q4 FY26)
Net Profit: ₹0.46Cr as on March 2026 (Q4 FY26)
Chairperson Name: K Koteswara Rao
| Organisation | Transgene Biotek Ltd |
| Industry | Healthcare |
| CEO | K Koteswara Rao |
| E-voting on shares | Click here to vote |
FAQs
What is Transgene Biotek share price today?
Transgene Biotek share price today stands at ₹3.08 as on at the close of the market. Transgene Biotek share today touched a day high of ₹3.14 and a low of ₹3.02.
What is the 52 week high and 52 week low range for Transgene Biotek share?
Transgene Biotek touched a 52 week high of ₹5.26 and a 52 week low of ₹1.83. Transgene Biotek share price today i.e. is closed at ₹3.08, which is -41.44% down from its 52 week high and 68.31% up from its 52 week low.
What is Transgene Biotek's market capitalisation today?
Transgene Biotek market capitalisation is ₹23.26 Cr as on .
How to buy Transgene Biotek shares?
To buy Transgene Biotek shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for 526139 or Transgene Biotek Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Transgene Biotek shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Transgene Biotek trading volume today?
Transgene Biotek trading volume is 3,219.00 as on . This means that 3,219.00 shares of Transgene Biotek were bought and sold on the stock market during today's trading session.